United States - English - NLM (National Library of Medicine)

hameln pharmaceuticals - pentetate calcium trisodium (unii: g79yn26h5b) (pentetic acid - unii:7a314hqm0i) - injection, solution, concentrate - 200 mg in 1 ml - ca-dtpa is indicated for treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination. none known.

United States - English - NLM (National Library of Medicine)

hameln pharma gmbh - pentetate calcium trisodium (unii: g79yn26h5b) (pentetic acid - unii:7a314hqm0i) - pentetate calcium trisodium 1000 mg in 5 ml - ca-dtpa is indicated for treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination. none. pregnancy category c risk summary there are no adequate and well-controlled studies of ca-dtpa use in pregnant women. ca-dtpa chelation therapy causes depletion of body stores of zinc, a trace metal essential for fetal development [see warnings and precautions (5.2)] . the consequences of zinc depletion and results of animal studies suggest a teratogenic risk in humans. ca-dtpa was teratogenic and embryotoxic in mice at daily doses 2 to 8 times the recommended daily human dose, based on body surface area (bsa), with a dose-dependent increase in the frequency of gross malformations. ca-dtpa was teratogenic in dogs at approximately half the recommended daily human dose based on bsa, as described below. there are no animal or human data evaluating the teratogenic effect of a single dose of ca-dtpa. ca-dtpa should be used during pregnancy

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - calcium trisodium pentetate - powder for solution for injection - 9.10 mg milligram - technetium (99mtc) compounds; technetium (99mtc) pentetic acid

Israel - English - Ministry of Health

isorad ltd, israel - calcium trisodium pentetate - solution for injection - calcium trisodium pentetate 20 mg/vial - technetium (99mtc) pentetic acid - technetium (99mtc) pentetic acid - kidney, brain, aerosol imaging.

Canada - English - Health Canada

edmonton radiopharmaceutical centre (alberta health services) - pentetate calcium trisodium - kit - 31.3mg - pentetate calcium trisodium 31.3mg - roentgenography

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate; calcium lactate gluconate; colecalciferol - tablets effervescent - calcium lactate gluconate 1358 mg; calcium carbonate 1050 mg; colecalciferol 4 mg - calcium lactate gluconate - calcium lactate gluconate - calcium and vitamin d supplement. calcium helps in the maintenance of bones and teeth. vitamin d helps in the absorption and use of calcium.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - calcium lactobionate; calcium gluconate - oral solution/suspension - calcium lactobionate mineral-calcium active 24.25 g/100ml; calcium gluconate mineral-calcium-salt active 10.39 g/100ml - nutrition & metabolism - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - calcium supplement

Israel - English - Ministry of Health

medic trim healthcare ltd - calcium gluconate - solution for injection - calcium gluconate 902.5 mg / 10 ml - calcium gluconate - calcium gluconate - all conditions where injectable calcium supplement is indicated.

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - calcium (as carbonate); calcium (as lactate gluconate) - tablets effervescent - calcium (as lactate gluconate) 149.7 mg; calcium (as carbonate) 350.3 mg - calcium gluconate - calcium gluconate - oral calcium therapy.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.